[1] LEE S,CHOI E J,JIN C,et al.Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line[J].Gynecologic Oncology,2005,97:26-34.
[2] GOMES C P,ANDRADE L A.PTEN and p53 expression in primary ovarian carcinomas:immunohistochemical study and discussion of pathogenetic mechanisms[J].Int J Gynecol Cancer,2006,16:254-258.
[3] LEONARDO E,VOLANTE M,BARBARESCHI M,et al.Cell membrane reactivity of MIB-1 antibody to Ki67 in human tumors:fact or artifact[J].Appl Immunohistochem Mol Morphol,2007,15(2):220-223.
[4] 陈昊,李玉民,何明彦,等.胃不典型增生和癌组织中Ki67和PTEN蛋白的表达及意义[J].中国普外基础与临床杂志,2007,3:304-307.
[5] 谷化平.CD44v6和E-cadherin表达与肺癌的关系[J].东南大学学报:医学版,2010,29(2):203-205.
[6] 陈雪松,赵艳滨,蔡莉,等.血管紧张素II受体1、VEGF和PTEN在乳腺癌中的表达及临床意义[J].中国肿瘤,2008,17(3):230-232.
[7] van RIJN S J,GRINWIS G C,PENNING L C,et al.Expression of Ki-67,PCNA,and p27kip1 in canine pituitary corticotroph adenomas[J]. Domest Anim Endocrinol,2010,38(4):244-252.
[8] WANG Y,WANG X,ZHANG J,et al.MicroRNAs involved in the EGFR/ PTEN/AKT pathway in gliomas[J].J Neurooncol,2012,106(2):217-224.
[9] 张航,钱科卿,闵海燕,等. PTTG和bFGF在非小细胞肺癌中的表达及其临床意义[J].东南大学学报:医学版,2009,28(3):217-221.
[10] YOSHIMOTO M,CUTZ J C,NUIN P A,et al.Interphase FISH analysis of PTEN in histologic of sections shows genomic deletions in 68% of primary prostate cancer and 23% high-grade prosraticintra-epithelial neoplasias[J].Cancer Genet Cytogenet,2006,169:128-137.
[11] GALLARDO A,LERMA E,ESCUIN D,et al.Increased signalling of EGFR and IGF1R,and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas[J].Br J Cancer,2012,106(8):1367-1373.
[12] KINROSS K M,MONTGOMERY K G,KLEINSCHMIDT M,et al.An activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice[J].J Clin Invest,2012,122(2):553-557.
[13] 张全安,徐瀚峰.非小细胞肺癌LRP、c-erbB-2蛋白表达与辅助化疗疗效相关性的研究[J].东南大学学报:医学版,2008,47(6):451-453.
[14] GONZALEZ-MOLES M A,RUIZ-AVILA I,GIL-MONTOYA J A,et al.Analysis of Ki-67 expression in oral squamous cell carcinoma:why Ki-67 is not a prognostic indicator[J].Oral oncology,2010,46(7):525-530.
[15] DOWSETT M,NIELSEN T O,A'HERN R,et al.Assessment of ki67 in breast cancer: recommendations from the international Ki67 in breast cancer working group[J].J Nati Cancer Inst,2011,103(22):1656-1664. |